GAMMA Investing’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-63
Closed -$105 3620
2024
Q2
$105 Hold
63
﹤0.01% 3404
2024
Q1
$117 Hold
63
﹤0.01% 3278
2023
Q4
$112 Buy
+63
New +$94 ﹤0.01% 3141

Other funds holding NBP

GAMMA Investing's NBP Position: Q3 2024 in Review

GAMMA Investing sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2024, closing a stake of 63 shares — an estimated $105 sold.

GAMMA Investing first reported a position in NBP in Q4 2023 and held it in 3 quarters. The position peaked at $117 in Q1 2024. 28 funds tracked by Wall St. Rank hold NBP as of Q3 2024.

  • GAMMA Investing reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • GAMMA Investing sold 63 NovaBridge Biosciences American Depositary Shares shares in Q3 2024, an estimated $105.
  • GAMMA Investing first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2023 and held it in 3 quarters.
  • GAMMA Investing's NovaBridge Biosciences American Depositary Shares position peaked at $117 in Q1 2024.
  • 28 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2024.

Based on GAMMA Investing's 13F filing for Q3 2024, filed 7 Oct 2024.